Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

This study has been completed.
Sponsor:
Collaborator:
Samsung Medical Center
Information provided by (Responsible Party):
SillaJen, Inc. ( Jennerex Biotherapeutics )
ClinicalTrials.gov Identifier:
NCT01380600
First received: June 22, 2011
Last updated: January 6, 2016
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)